Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPS for Balance and Fall Risk in Parkinson Disease
NCT02812147Phase 2Unknown
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- May 2016
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing L-DOPS Sequence with Placebo Sequence (2 arms). Primary endpoints: Motor Score at 4 months, Balance Score at 4 months and 3 more. Status: unknown.
02
Drugs
droxidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02812147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812147.